Our studies demonstrate that ASA treatment inhibits SOX2 gene expression and modulation of SOX2 by PGF2α attenuates ASA-induced inhibition of survival and induction of apoptosis in murine B16F10 melanoma cells. This evidence concerns the gene SOX2 and melanoma.